Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Direct to consumer Internet advertising of statins: an assessment of safety.

Williams B, Brown D.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):352-65. doi: 10.1002/pds.3208. Epub 2012 Feb 2. Retraction in: Brown D, Williams B. Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1137. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):909.

PMID:
22298504
2.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

3.
4.

Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.

Bradford WD, Kleit AN, Nietert PJ, Ornstein S.

Clin Ther. 2006 Dec;28(12):2105-18; discussion 2104.

PMID:
17296467
5.

A systematic review and meta-analysis on the therapeutic equivalence of statins.

Weng TC, Yang YH, Lin SJ, Tai SH.

J Clin Pharm Ther. 2010 Apr;35(2):139-51. doi: 10.1111/j.1365-2710.2009.01085.x. Review.

PMID:
20456733
6.

An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.

Einarson TR, Metge CJ, Iskedjian M, Mukherjee J.

Clin Ther. 2002 Dec;24(12):2126-36. Erratum in: Clin Ther. 2003 Dec;25(12):3190.

PMID:
12581550
7.

Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.

Plans-RubiĆ³ P.

Am J Cardiovasc Drugs. 2006;6(3):177-88.

PMID:
16780391
9.

Developing a consumer evaluation tool of weight control strategy advertisements on the Internet.

Luevorasirikul K, Gray NJ, Anderson CW.

Health Educ Res. 2008 Jun;23(3):567-75. Epub 2007 Sep 7.

PMID:
17827469
11.

An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).

Smith DG, McBurney CR.

Pharmacoeconomics. 2003;21 Suppl 1:13-23.

PMID:
12648031
12.

Back pain online: a cross-sectional survey of the quality of web-based information on low back pain.

Butler L, Foster NE.

Spine (Phila Pa 1976). 2003 Feb 15;28(4):395-401.

PMID:
12590218
13.

Economic implications of lipid-lowering trials: current considerations in selecting a statin.

Farmer JA.

Am J Cardiol. 1998 Sep 24;82(6A):26M-31M. Review.

PMID:
9766345
14.

Pharmaceutical websites and the communication of risk information.

Davis JJ, Cross E, Crowley J.

J Health Commun. 2007 Jan-Feb;12(1):29-39.

PMID:
17365347
15.
16.

Cost-effectiveness of statins.

Huse DM, Russell MW, Miller JD, Kraemer DF, D'Agostino RB, Ellison RC, Hartz SC.

Am J Cardiol. 1998 Dec 1;82(11):1357-63.

PMID:
9856919
17.

Impact of restricted reimbursement on the use of statins in Finland: a register-based study.

Martikainen JE, Saastamoinen LK, Korhonen MJ, Enlund H, Helin-Salmivaara A.

Med Care. 2010 Sep;48(9):761-6. doi: 10.1097/MLR.0b013e3181e41bcb.

PMID:
20706164
18.

Surfing for mouth guards: assessing quality of online information.

Magunacelaya MB, Glendor U.

Dent Traumatol. 2011 Oct;27(5):334-43. doi: 10.1111/j.1600-9657.2011.01017.x. Epub 2011 Jun 3.

PMID:
21635690
19.

Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.

Derks M, Abt M, Phelan M, Turnbull L, Meneses-Lorente G, Bech N, White AM, Parr G.

J Clin Pharmacol. 2010 Oct;50(10):1188-201. doi: 10.1177/0091270009358709. Epub 2010 May 20.

PMID:
20489031
20.

[Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor].

Bousquet P, Gayet JL.

Therapie. 2003 Mar-Apr;58(2):113-21. Review. French.

PMID:
12942850

Supplemental Content

Support Center